Tech Company Financing Transactions

Onward Therapeutics Funding Round

Onward Therapeutics, based in Taipei, scored $28 million from CDIB Capital Group, Hercules Capital and Taiwania Capital.

Transaction Overview

Announced On
11/18/2026
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to advance its clinical programs, manufacture clinical supplies, and support early-stage R&D, while expanding its team and initiating clinical trials in Taiwan.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
No. 60, Songjiang Road, Zhongshan District 2F
Taipei, 104090
Taiwan
Phone
Undisclosed
Email Address
Overview
We are a clinical-stage oncology company focused on identifying innovative technologies and advancing truly breakthrough medicines for the treatment of cancer. Led by an experienced team in translational science and drug development, we acquire licenses for high potential development candidates, we invest in partners with transformative technology platforms, and we build our own internal programs.
Profile
Onward Therapeutics LinkedIn Company Profile
Social Media
Onward Therapeutics Company Twitter Account
Company News
Onward Therapeutics News
Facebook
Onward Therapeutics on Facebook
YouTube
Onward Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Grace Yeh
  Grace Yeh LinkedIn Profile  Grace Yeh Twitter Account  Grace Yeh News  Grace Yeh on Facebook
Chief Medical Officer
Alain Herrera
  Alain Herrera LinkedIn Profile  Alain Herrera Twitter Account  Alain Herrera News  Alain Herrera on Facebook
Chief Operating Officer
Patrick Nielly
  Patrick Nielly LinkedIn Profile  Patrick Nielly Twitter Account  Patrick Nielly News  Patrick Nielly on Facebook
President
Armand de Gramont
  Armand de Gramont LinkedIn Profile  Armand de Gramont Twitter Account  Armand de Gramont News  Armand de Gramont on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/18/2026: Sequel.io venture capital transaction
Next: 11/19/2026: StepSecurity venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary